CSL Delays Seqirus Spinout Until Flu Vaccine Sales Stabilize

FY26 Guidance Lowered On Albumin, Vaccine Slumps

 
• By Mandy Jackson
  
CSL identified a 12% decline in US influenza vaccination and a 14% drop for adults aged 65 and older (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Scrip

More from Strategy